Data / Drug companies / Nucleic Products, LLC
Nucleic Products, LLC: 12 products in the FDA NDC directory, labeler code 75053
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Nucleic Products, LLC (labeler code 75053) lists 12 products in the FDA National Drug Code Directory. By type: 12 over the counter drugs. Its main marketing category is unapproved homeopathic products. The newest product started marketing on February 27, 2026.
The request: Watch Nucleic Products, LLC (FDA labeler code 75053): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 75053
- Products in commercial distribution
- 12
- Packages
- 12
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 12
- Flagged as original packager
- 11 of 11 products that carry the flag
- Started marketing in the last 12 months
- 1
- Products with a marketing end date set
- 3
- Earliest marketing start
- June 29, 2020
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Unapproved homeopathic products | 12 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 12 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Liquid | 12 | 100% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Influenseg | 75053-0100 | Liquid | Unapproved homeopathic products | February 27, 2026 |
| Oxaltem | 75053-0012 | Liquid | Unapproved homeopathic products | May 21, 2024 |
| Influenseg | 75053-0011 | Liquid | Unapproved homeopathic products | June 20, 2022 |
| Oxaltem | 75053-0009 | Liquid | Unapproved homeopathic products | January 31, 2022 |
| Apnetem | 75053-0008 | Liquid | Unapproved homeopathic products | May 18, 2021 |
| Hypothaltem | 75053-0010 | Liquid | Unapproved homeopathic products | May 11, 2021 |
| Celltem | 75053-0003 | Liquid | Unapproved homeopathic products | May 3, 2021 |
| Gallcill | 75053-0006 | Liquid | Unapproved homeopathic products | April 19, 2021 |
| Cerebellutem | 75053-0005 | Liquid | Unapproved homeopathic products | April 19, 2021 |
| Excitathyrotem | 75053-0004 | Liquid | Unapproved homeopathic products | October 13, 2020 |
| Lymphocil | 75053-0002 | Liquid | Unapproved homeopathic products | June 29, 2020 |
| Neuroinflammacil | 75053-0001 | Liquid | Unapproved homeopathic products | June 29, 2020 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.